| Targeted Alpha Particle Radiotherapy for Metastatic Uveal Melanoma (NCT05496686) | Modulation Therapeutics, Inc. | 2022-07-21 |
| Single Arm Trial of Tumor-Treating Fields in Combination With Nivolumab and Ipilimumab in Metastatic Uveal Melanoma (NCT05004025) | HonorHealth Research Institute | 2022-02-28 |
| A Prospective Natural History Study in Uveal Melanoma (NCT04588662) | Columbia University | 2021-05-06 |
| Melphalan Chemoreduction for Ocular Melanoma (NCT05893654) | Hospital das Clínicas de Ribeirão Preto | 2021-05-01 |
| The Role of Genetic Mutations and of Circulating mRNAs in Uveal Melanoma (NCT05179174) | University of Catania | 2021-04-20 |
| Isolated Hepatic Perfusion in Combination With Ipilimumab and Nivolumab in Patients With Uveal Melanoma Metastases (NCT04463368) | Vastra Gotaland Region | 2021-03-08 |
| Study of PAC-1 and Entrectinib for Patients With Metastatic Uveal Melanoma (NCT04589832) | Arkadiusz Z. Dudek, MD | 2021-01-11 |
| A Study of RO7293583 in Participants With Unresectable Metastatic Tyrosinase Related Protein 1 (TYRP1)-Positive Melanomas (NCT04551352) | Hoffmann-La Roche | 2020-10-28 |
| Melanoma Vaccine Against Neoantigen and Shared Antigens by CD40 Activation and TLR Agonists In Patients With Melanoma (Including Ocular Melanoma) (NCT04364230) | Craig L Slingluff, Jr | 2020-09-28 |
| Phase 2 Trial to Evaluate Belzupacap Sarotalocan (AU-011) Via Suprachoroidal Administration in Subjects With Primary Indeterminate Lesions and Small Choroidal Melanoma (NCT04417530) | Aura Biosciences | 2020-08-05 |
| Early Integration of Supportive Care for Metastatic Uveal Melanoma Patients (EarlyTogether) (NCT04728113) | Institut Curie | 2020-07-16 |
| Follow-up of Patients With Uveal Melanoma Adapted to the Risk of Relapse (SALOME) (NCT04424719) | Institut Curie | 2020-07-08 |
| Durvalumab (MEDI4736) Plus Cediranib in Patients With Metastatic Uveal Melanoma (NCT04184518) | Grupo Español Multidisciplinar de Melanoma | 2020-05-01 |
| A Study to Assess a PI3Kδ Inhibitor (IOA-244) in Patients With Metastatic Cancers (NCT04328844) | iOnctura | 2020-02-25 |
| Vorinostat in Patients With Class 2 High Risk Uveal Melanoma (NCT03022565) | University of Miami | 2020-01-01 |
| Stereotactic Body Radiation Therapy and Aflibercept in Treating Patients With Uveal Melanoma (NCT03712904) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2019-08-09 |
| C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N) (NCT03635632) | Baylor College of Medicine | 2019-04-23 |
| Study of Immunotherapy Plus ADI-PEG 20 for the Treatment of Advanced Uveal Melanoma (NCT03922880) | Memorial Sloan Kettering Cancer Center | 2019-04-16 |
| Prospective Registration Of Patient Data and Quality of Life in Eye Melanoma Patients (NCT05377957) | Leiden University Medical Center | 2019-03-05 |
| A Phase 1 Study of [225Ac]-FPI-1434 Injection (NCT03746431) | Fusion Pharmaceuticals Inc. | 2019-01-17 |
| A Safety and Tolerability Study of INCAGN02390 in Select Advanced Malignancies (NCT03652077) | Incyte Corporation | 2018-09-24 |
| A Study of APG-115 in as a Monotherapy or Combination With Pembrolizumab in Patients With Metastatic Melanomas or Advanced Solid Tumors (NCT03611868) | Ascentage Pharma Group Inc. | 2018-08-29 |
| A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001) (NCT03207347) | University of Florida | 2018-08-13 |
| CAVATAK® and Ipilimumab in Uveal Melanoma Metastatic to the Liver (VLA-024 CLEVER) (NCT03408587) | Viralytics | 2018-01-29 |
| Safety and Efficacy of IMCgp100 Versus Investigator Choice in Advanced Uveal Melanoma (NCT03070392) | Immunocore Ltd | 2017-10-16 |
| Intermittent Selumetinib for Uveal Melanoma (NCT02768766) | Shaheer A. Khan | 2017-02-28 |
| Study in Subjects With Small Primary Choroidal Melanoma (NCT03052127) | Aura Biosciences | 2017-02-27 |
| Study of the Activity of PD-1 Inhibitors in Metastatic Uveal Melanoma (NCT03964298) | Institut Curie | 2016-11-01 |
| Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases (NCT02913417) | David Minor, MD | 2016-10-10 |
| Study Evaluating Single and Repeated Intravitreal Doses of ICON-1 in Patients With Uveal Melanoma (NCT02771340) | Iconic Therapeutics, Inc. | 2016-05-01 |
| Trial of Nivolumab in Combination With Ipilimumab in Subjects With Previously Untreated Metastatic Uveal Melanoma (NCT02626962) | Grupo Español Multidisciplinar de Melanoma | 2016-04-01 |
| A Study of the Intra-Patient Escalation Dosing Regimen With IMCgp100 in Patients With Advanced Uveal Melanoma (NCT02570308) | Immunocore Ltd | 2016-02-29 |
| A Phase I Study of LXS196 in Patients With Metastatic Uveal Melanoma. (NCT02601378) | Novartis Pharmaceuticals | 2016-02-01 |
| Transarterial Radioembolisation in Comparison to Transarterial Chemoembolisation in Uveal Melanoma Liver Metastasis (NCT02936388) | Charite University, Berlin, Germany | 2016-01-01 |
| Frequency and Clinical Phenotype of BAP1 Hereditary Predisposition Syndrome (NCT04792463) | Mohamed Abdel-Rahman | 2015-03-03 |
| Crizotinib in High-Risk Uveal Melanoma Following Definitive Therapy (NCT02223819) | Columbia University | 2015-03-01 |
| TTT Versus TTT and Triamcinolone to Decrease Exudation in Choroidal Melanoma After Proton Beam Therapy (NCT02379000) | Charite University, Berlin, Germany | 2015-01-01 |
| Trial of AEB071 in Combination With BYL719 in Patients With Melanoma (NCT02273219) | Columbia University | 2014-11-19 |
| Evaluation Interest of the Circulating Tumor DNA Dosage in Patient With Hepatic Metastatic Uveal Melanoma Candidate to Complete Resection (ct DNA R0) (NCT02849145) | Institut Curie | 2014-09-01 |
| Dendritic Cells Plus Autologous Tumor RNA in Uveal Melanoma (NCT01983748) | University Hospital Erlangen | 2014-08-05 |
| Ph 1 Study in Subjects With Tumors Requiring Arginine to Assess ADI-PEG 20 With Pemetrexed and Cisplatin (NCT02029690) | Polaris Group | 2014-04-23 |
| Selumetinib (AZD6244: ARRY-142886) (Hyd-Sulfate) in Metastatic Uveal Melanoma (SUMIT) (NCT01974752) | AstraZeneca | 2014-04-01 |
| Dexamethasone Intravitreal Implant for Treatment of Macular Edema After Plaque Radiotherapy of Uveal Melanoma (NCT01471054) | Arman Mashayekhi | 2014-04-01 |
| Vascular Response to Brachytherapy Using Functional OCT (NCT01955941) | OHSU Knight Cancer Institute | 2013-10-01 |
| A Phase Ib/II Study of AEB071 and MEK162 in Adult Patients With Metastatic Uveal Melanoma (NCT01801358) | Array Biopharma, now a wholly owned subsidiary of Pfizer | 2013-08-01 |
| New Biopsy Technique for Uveal Melanoma (NCT01924923) | Greater Houston Retina Research | 2013-06-01 |
| Endoresection of the Tumor Scar or Transpupillary Thermotherapy for the Treatment of Large Uveal Melanomas (Endoresection-Laser) (NCT02874040) | Institut Curie | 2013-04-19 |
| Influence of Oral Treatment With Citicoline for the Prevention of Radiation Optic Neuropathy in Patients Treated for Uveal Melanomas With Proton Beam Therapy (NCT01338389) | Centre Hospitalier Universitaire de Nice | 2012-06-25 |
| Study Multicentre Evaluating the Effectiveness and Toxicity Sorafenib (Nexavar®) in Adult Patients With Uveal Melanoma and Metastatic Dissemination (NCT02517736) | University Hospital, Caen | 2012-02-01 |
| Safety and Efficacy of AEB071 in Metastatic Uveal Melanoma Patients (NCT01430416) | Novartis Pharmaceuticals | 2011-12-20 |
| Assessing the Clinical Effectiveness of Serum Biomarkers in the Diagnosis of Metastatic Uveal Melanoma (NCT01438658) | Hadassah Medical Organization | 2011-09-01 |
| A Study of Sorafenib in Patients With Chemonaive Metastatic Uveal Melanoma (NCT01377025) | Prof. Dr. med. Max. E. Scheulen | 2011-06-01 |
| Uveal Melanoma and Brachytheraphy: Long-term Outcomes. (NCT04577742) | Federico II University | 2011-02-01 |
| RAD001 (Everolimus) and Pasireotide (SOM230) LAR in Patients With Advanced Uveal Melanoma (NCT01252251) | Memorial Sloan Kettering Cancer Center | 2010-11-01 |
| 5 Year Registry Study to Track Clinical Application of DecisionDx-UM Assay Results and Associated Patient Outcomes (NCT02376920) | Castle Biosciences Incorporated | 2010-03-01 |
| Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma (NCT01034787) | AHS Cancer Control Alberta | 2009-08-17 |
| Comparison Between Fotemustin to Intensive Surveillance in Patients With High Risk Uveal Melanoma (NCT02843386) | Institut Curie | 2009-06-23 |
| Messenger Ribonucleic Acid (mRNA) Transfected Dendritic Cell Vaccination in High Risk Uveal Melanoma Patients (NCT00929019) | Radboud University Medical Center | 2009-06-01 |
| Hypofractionated Stereotactic Linear Accelerator Radiotherapy of Uveal Melanoma (NCT00872391) | Medical University of Vienna | 2009-03-01 |
| Morphological, Genetic and Tumour Microenvironment Characterisation in Uveal Melanoma (NCT05889481) | Fondazione Policlinico Universitario Agostino Gemelli IRCCS | 2008-01-01 |
| Intravitreal Ranibizumab for the Prevention of Radiation Maculopathy Following Plaque Radiotherapy (NCT00540930) | Shields, Shields and Associates | 2007-04-01 |
| Treatment With Intravitreal Avastin for Large Uveal Melanomas (NCT00596362) | Memorial Sloan Kettering Cancer Center | 2007-04-01 |
| Combined PET/CT Imaging for the Early Detection of Ocular Melanoma Metastasis Compared to CT Scanning Alone (NCT00351728) | Jonsson Comprehensive Cancer Center | 2006-06-01 |
| Vorinostat in Treating Patients With Metastatic or Unresectable Melanoma (NCT00121225) | National Cancer Institute (NCI) | 2005-09-01 |
| Halt Growth of Liver Tumors From Uveal Melanoma With Closure of Liver Artery Following Injection of GM-CSF (NCT00661622) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2004-10-01 |
| Tilting of Radioactive Plaques After Initial Accurate Placement for Treatment of Uveal Melanoma (NCT00459849) | Barnes Retina Institute | 2000-07-01 |
| A Cohort IND Expanded Access Program for Supporting Patient Access to Tebentafusp (NCT04960891) | Immunocore Ltd | |